CT
Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
NASDAQ·Healthcare·Biotechnology
$12.84
+3.55%
Mkt Cap $444.15M
Analyst Ratings
Buy
1
Hold
2
Sell
0
Price Target (9 analysts)
$17.33
Range $14.00 – $22.00
Implied Upside
+35.0%
Consensus $17.33 vs current $12.84